Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Skye Bioscience Logo
Skye Bioscience Growth Score
88
CB Rank
50640
Heat Score
63
Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.
Founded
obfuscation
PublicPost-IPO Equity San Diego, California, United States11-50 skyebioscience.com
Biotechnology
Medical
Pharmaceutical
Overview

Skye Bioscience
Total Funding
obfuscation
Growth Score
88
Heat Score
63

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score88
-5 pts
in past quarter
Heat Score 63
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Skye Bioscience

CB Rank
50640
Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.
Founded
obfuscation
PublicPost-IPO Equity San Diego, California, United States11-50 skyebioscience.com
Biotechnology
Medical
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Skye Bioscience, Inc.
Also Known As Load Guard Logistics, Load Guard Transportation, Nemus Bioscience, Emerald Bioscience
Operating Status Active
Stock Symbol  NASDAQ:SKYE
Company Type For Profit
Founders  Cosmas Lykos
About the Company
Skye Bioscience is a pharmaceutical company providing new therapeutic outcomes for diseases with significant prevalence and unmet needs. It develops proprietary molecules to treat diseases involving inflammatory, fibrotic, and metabolic conditions.
Phone Number (949) 396-0330
Contact Email info@skyebioscience.com
Predictions & Insights

Growth Insight

See this Growth Insight
Skye Bioscience is
Lorem
 to be growing
Top Contributing Factors
Financial Decline

Products & Services

Nimacimab
A peripheral CB1 receptor inhibiting antibody developed to treat obesity by increasing energy expenditure and fat breakdown with limited central nervous system effects.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 10
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
5
obfuscation
5AM VenturesPost-IPO Equity
obfuscation
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
5
obfuscation
5AM VenturesPost-IPO Equity
obfuscation
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
5
obfuscation
5AM VenturesPost-IPO Equity
obfuscation
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
5
obfuscation
5AM VenturesPost-IPO Equity
obfuscation
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
5
obfuscation
5AM VenturesPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 10
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
5
obfuscation
5AM VenturesPost-IPO Equity
obfuscation
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
5
obfuscation
5AM VenturesPost-IPO Equity
obfuscation
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
5
obfuscation
5AM VenturesPost-IPO Equity
obfuscation
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
5
obfuscation
5AM VenturesPost-IPO Equity
obfuscation
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
5
obfuscation
5AM VenturesPost-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Altium Capital Logo
Altium Capital
—
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
—
Altium Capital Logo
Altium Capital
—
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
—
Altium Capital Logo
Altium Capital
—
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
—
Altium Capital Logo
Altium Capital
—
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
—
Altium Capital Logo
Altium Capital
—
Post-IPO Equity - Skye Bioscience Logo
Post-IPO Equity - Skye Bioscience
—

Investments

Number of Acquisitions 2

Investment Breakdown

Number of Acquisitions 2
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 7 Board Members and Advisors 1 Contacts 6

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,581
-80.07%
 in past month

IT Spend

$480.4KThis year, Skye Bioscience is projected to spend $480.4K on IT, according to Aberdeen.

Actively Used Products

9Skye Bioscience uses 9 technology products and services including HTML5, HTML5, and  Microsoft Outlook, according to G2 Stack.

Active Website Tech Count

5Skye Bioscience is actively using 5 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, Common Name Invalid, and  COVID-19.

Total IP

1Skye Bioscience has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Skye Bioscience's headquarters? Skye Bioscience is located in San Diego, California, United States.Who invested in Skye Bioscience? Skye Bioscience has 9 investors including Altium Capital and  Sphera Global Healthcare Fund.When was the last funding round for Skye Bioscience? Skye Bioscience closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Skye Bioscience's competitors? Alternatives and possible competitors to Skye Bioscience may include Kailera Therapeutics, BioAge Labs, and  MBX Biosciences.How much funding has Skye Bioscience raised to date? Skye Bioscience has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|